An investment fund located in Western Europe focuses on early-stage life science investments, more specifically in drug development, medical devices, and diagnostics. The fund makes Pre-Seed, Seed, and Series A investments with an investment sweet spot of around €1.5 M. The maximum investment in one project can be €5.3 M in several rounds, preferentially in equity investments. The firm is led by an experienced team of professionals with backgrounds in private equity, the healthcare industry, and venture capital, who can support entrepreneurs on their journey to global success. Thanks to close cooperation with the fund’s main sponsor, a leading biotech incubator, the firm has a great opportunity to be at the origin of transformative Central European technologies.
The firm is seeking opportunities in drug development, medical devices, diagnostics, and other life sciences. The firm is agnostic to subsectors and indications, and expects to see some pre-clinical data (ideally in vivo PoC) from the start-up companies, to consider investment.
The firm is open to all types of management teams. The firm can lead the investment round under specific circumstances, or co-invest and will seek a board seat when leading. The firm prefers to syndicate for all of their investments.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment